APA (7th ed.) Citation

Neben, K., Mytilineos, J., Möhler, T., Preiss, A., Krämer, A., Ho, A. D., . . . Goldschmidt, H. (2002). Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood, 100(6), . https://doi.org/10.1182/blood.V100.6.2263

Chicago Style (17th ed.) Citation

Neben, Kai, Joannis Mytilineos, Thomas Möhler, Astrid Preiss, Alwin Krämer, Anthony Dick Ho, Gerhard Opelz, and Hartmut Goldschmidt. "Polymorphisms of the Tumor Necrosis Factor-α Gene Promoter Predict for Outcome After Thalidomide Therapy in Relapsed and Refractory Multiple Myeloma." Blood 100, no. 6 (2002). https://doi.org/10.1182/blood.V100.6.2263.

MLA (9th ed.) Citation

Neben, Kai, et al. "Polymorphisms of the Tumor Necrosis Factor-α Gene Promoter Predict for Outcome After Thalidomide Therapy in Relapsed and Refractory Multiple Myeloma." Blood, vol. 100, no. 6, 2002, https://doi.org/10.1182/blood.V100.6.2263.